Evaluation of Eosinophil-Associated Gastrointestinal Disorders
What is the purpose of this study?
The Cincinnati Center for Eosinophilic Disorders at Cincinnati Children's Hospital Medical Center is currently conducting a clinical and immunological evaluation of eosinophil-associated gastrointestinal disorders. The purpose of this study is to conduct a translational study in patients with primary eosinophil-associated gastrointestinal disorders [EGID] with the aim of developing a databank containing pertinent patient demographic information, tissue samples and DNA. Eosinophil-associated gastrointestinal disorders [EGID] include:
- Eosinophilic esophagitis
- Eosinophilic gastritis
- Eosinophilic enteritis [EE]
- Eosinophilic colitis
- Eosinophilic gastroenteritis [EGE]
This information will facilitate research on the pathophysiology of inflammatory disorders and the development of a verified successful clinical treatment program.
Who can participate?
- > 3 years of age
- Clinical symptoms consistent with EGID (e.g., refractory abdominal pain, vomiting, dysphagia)
- Patients with presumed gastrointestinal reflux disease (GERD) that is refractory to therapy
- Eosinophilic Disorders
- Gastroenterology, Hepatology and Nutrition
Who should I contact for more information?
If you are a patient who may be interested in enrolling in this research study or you have further questions, please contact us at 513-636-5540.